S O Lundstam, K H Leissner, L A Wåhlander, J G Kral. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAgedAnalgesics, Opioid/adverse effectsAnalgesics, Opioid/therapeutic useCodeine/adverse effectsCodeine/therapeutic useColic/drug therapyCyclooxygenase InhibitorsDiclofenac/adverse effectsDiclofenac/pharmacologyDiclofenac/therapeutic useDouble-Blind MethodDrug Combinations/adverse effectsDrug Combinations/therapeutic useFemaleHumansInjections, IntramuscularKidney Diseases/drug therapyMaleMiddle AgedMorphine/adverse effectsMorphine/therapeutic useNoscapine/adverse effectsNoscapine/therapeutic usePapaverine/adverse effectsPapaverine/therapeutic usePhenylacetates/therapeutic useRandom AllocationScopolamine Derivatives/adverse effectsScopolamine Derivatives/therapeutic use
Substances: See more » Analgesics, OpioidCyclooxygenase InhibitorsDrug CombinationsPhenylacetatesScopolamine DerivativesDiclofenacMorphinespasmofenNoscapinePapaverineCodeine
Year: 1982 PMID: 6122892 DOI: 10.1016/s0140-6736(82)92278-4
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321